Welcome to our dedicated page for Abacus Global Management SEC filings (Ticker: ABXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Abacus Global Management's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Abacus Global Management's regulatory disclosures and financial reporting.
Abacus Global Management, Inc. (ABX) furnished a shareholder letter providing a valuation update and mid‑year outlook. Management explains that the discount rate on life insurance policy sales has closely tracked the Federal Funds Effective Rate, widening from 12% to above 21% during 2022‑2023 and compressing to about 10% by Q1 2026, while average realized gains on policy sales have remained in the low‑ to mid‑20% range, with one quarter in the mid‑30% range.
Beginning in Q2 2026, Abacus adopted a market‑based Historical Return Method for valuing policies, applying observed realized returns to cost basis instead of discounting modeled cash flows. The company highlights rapid balance‑sheet turnover near or above its 1.5x–2.0x annualized target, using recent quarters of 2.6x, 1.9x, and 2.0x as evidence that carrying values are regularly validated by cash sales.
For Q2 2026, revenue rose 30% year over year to $73.0 million, led by Life Solutions growth of 38.3%. Adjusted net income was $27.1 million, and adjusted EBITDA grew 27% to $39.9 million with a margin near 55%. Abacus deployed about $200 million of capital in Q2 and $362 million year‑to‑date, supported by more than $1 billion of fund capital commitments over the last twelve months and fund distributions at annualized rates up to 10%.
Abacus Global Management, Inc. (ABX) reported that officer William Hugh McCauley Jr., COO and CFO, sold 125,000 shares of common stock on August 20, 2026 in open market transactions at a weighted average price of $9.10 per share, with individual trades ranging from $8.92 to $9.23. According to the company’s disclosure, these sales were made to satisfy estimated tax obligations. After these transactions, McCauley directly holds 915,260 shares of Abacus Global Management common stock.
Abacus Global Management, Inc. (ABX) received a notice that William Hugh McCauley, its CFO and COO, intends to sell common stock under Rule 144. The planned sale covers 125,000 common shares through UBS Financial Services Inc., to be traded on the NYSE.
The filing lists an aggregate market value of $1,157,500 for these shares and states that 97,792,000 common shares were outstanding. The shares to be sold are linked to compensation-related RSU grants from Abacus Global Management, Inc., with acquisition dates in 2026.
Abacus Global Management, Inc. Chief Executive Officer and 10% owner Jackson Jay J reported selling 196,000 shares of Common Stock on 2026-08-12 in open-market transactions at a weighted average price of $8.77 per share. According to the disclosure, the sale was made to satisfy estimated tax obligations, and followed multiple trades within a price range of $8.53 to $9.07. After these transactions, Jackson directly holds 10,397,430 shares of Abacus Global Management, Inc. The Rule 10b5-1 trading plan checkbox was not marked as applicable.
Abacus Global Management, Inc. announced that its Board of Directors has authorized a new share repurchase program for up to $100 million of common stock. The program begins on August 17, 2026 and may continue through May 6, 2028.
Repurchases may occur in the open market or through privately negotiated transactions, including accelerated share repurchase transactions, block trades and Rule 10b5-1 trading plans. Abacus states that this authorization aligns with its capital allocation framework and follows approximately $80 million of stock repurchased under prior programs since December 2023.
The company expects to fund the program primarily from ongoing free cash flow generation and proceeds from balance sheet transactions, supplemented by cash on hand. Management highlights a strategy of balancing investment in origination growth, technology and acquisitions with returning capital to shareholders via this repurchase program.
Abacus Global Management, Inc. reported higher revenues but lower earnings for the quarter and six months ended June 30, 2026. Total revenue rose to $73.0 million from $56.2 million for the quarter and to $132.4 million from $100.4 million year-to-date, driven mainly by strong growth in the Life Solutions segment, which generated $65.4 million in quarterly revenue versus $47.3 million a year earlier.
Despite higher gross profit, net income attributable to Abacus declined to $6.6 million from $17.6 million for the quarter and to $13.9 million from $22.2 million for the six months, as general and administrative expenses and sales and marketing costs increased significantly and other income shifted unfavorably. Cash flow from operations was strong at $130.9 million versus $14.5 million a year earlier, aided by activity in life settlement policies and related party payables. The company ended the period with $23.4 million in cash, $383.0 million of life settlement policies at fair value, $330.6 million of total debt, and stockholders’ equity of $434.7 million, while continuing sizable share repurchases and investing $53.1 million to acquire a minority interest in Manning & Napier.
Abacus Global Management reported record second-quarter 2026 total revenue of $73.0 million, up 30% year-over-year, driven mainly by Life Solutions. GAAP net income declined to $6.6 million from $17.6 million as sales, marketing and general and administrative costs increased with growth and acquisitions.
Non‑GAAP measures increased: adjusted net income was $27.1 million and adjusted diluted EPS was $0.28, both exceeding the high end of guidance, while adjusted EBITDA reached a record $39.9 million with a 54.7% margin. Operating cash flow for the first half rose to $130.9 million from $14.5 million.
Abacus raised $544.2 million into longevity funds in the first half, surpassing its $500 million target, completed a $53 million minority stake in Manning & Napier, and launched its ABX Longevity Growth and Income interval fund. Guidance calls for FY26 adjusted EPS of $1.00–$1.05 and third‑quarter adjusted EPS of $0.26–$0.28, implying up to 17% year‑over‑year growth.
McNealy Sean reported reported sale transactions in this Form 4 filing.
Sean McNealy, a 10% owner of Abacus Global Management, Inc., disposed of 38,333 shares of common stock on August 3, 2026 by contributing them to the Fidelity Exchange Fund in exchange for an interest in that fund. The shares were valued at $10.31 per share, using Abacus Global Management’s closing share price on July 31, 2026. After this transaction he directly held 12,610,606 shares and indirectly held 86,207 shares through an LLC jointly owned with his spouse.
Kirby Kevin Scott reported reported sale transactions in this Form 4 filing.
Abacus Global Management, Inc. ten percent owner Kirby Kevin Scott reported a disposition of 38,334 shares of common stock on August 3, 2026. The shares were contributed to the Fidelity Exchange Fund in exchange for an interest in the fund and valued at $10.31 per share using the July 31, 2026 closing price. After the transaction he directly held 12,610,305 shares and indirectly held 86,207 shares through an LLC jointly owned with his spouse.